GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:541540) » Definitions » 14-Day RSI

Solara Active Pharma Sciences (BOM:541540) 14-Day RSI : 46.23 (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-06-09), Solara Active Pharma Sciences's 14-Day RSI is 46.23.

The industry rank for Solara Active Pharma Sciences's 14-Day RSI or its related term are showing as below:

BOM:541540's 14-Day RSI is ranked worse than
50.66% of 1141 companies
in the Drug Manufacturers industry
Industry Median: 46.11 vs BOM:541540: 46.23

Competitive Comparison of Solara Active Pharma Sciences's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's 14-Day RSI falls into.



Solara Active Pharma Sciences  (BOM:541540) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solara Active Pharma Sciences  (BOM:541540) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Solara Active Pharma Sciences 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences (BOM:541540) Business Description

Traded in Other Exchanges
Address
27. Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences (BOM:541540) Headlines

No Headlines